These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5661206)

  • 1. Deladroxate: a one-a-month intramuscular contraceptive.
    Bernell James WF
    J Natl Med Assoc; 1968 Jul; 60(4):314-7. PubMed ID: 5661206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monthly injection of combined estrogen and gestagen for contraception].
    Soffer U; Caspi E; Hirsch H
    Harefuah; 1974 Mar; 86(6):303-7. PubMed ID: 4831199
    [No Abstract]   [Full Text] [Related]  

  • 3. [Single monthly injection for contraception].
    Artner J; Friedrich F
    Geburtshilfe Frauenheilkd; 1970 Jun; 30(6):554-64. PubMed ID: 5475938
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical test with a prolonged-action estrogen-progesterone combination administered intramuscularly].
    Mateos Cándano M; Ochoa Bernal MR; Ruiz Moreno JA
    Ginecol Obstet Mex; 1969 Sep; 26(155):275-82. PubMed ID: 5402846
    [No Abstract]   [Full Text] [Related]  

  • 5. Conception control by a single monthly injection.
    Esquivel A; Laufe LE
    Obstet Gynecol; 1968 May; 31(5):634-6. PubMed ID: 5646393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphology of human ovaries after treatment with an injectable long-acting oestrogen-progestogen agent.
    Plesner R
    Acta Obstet Gynecol Scand; 1974; 53(2):169-76. PubMed ID: 4822348
    [No Abstract]   [Full Text] [Related]  

  • 7. The remote changes in the endometrial histology and the cervicovaginal cytology with the long acting hormonal contraceptive.
    Sammour MB; El-Hafiz MA
    Fertil Steril; 1970 Jun; 21(6):464-8. PubMed ID: 4927704
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of an injectable hormonal contraceptive in a single monthly dose].
    Chieffi O; Bonardi L; Brogioni M
    Arch Ostet Ginecol; 1974; 79(5-6):342-61. PubMed ID: 4471562
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Ovulation inhibitors in depot-form?].
    Lauritzen C
    MMW Munch Med Wochenschr; 1975 Feb; 117(9):361. PubMed ID: 804646
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
    Zaki K; Younis N; Nour H
    Egypt Popul Fam Plann Rev; 1971 Dec; 4(2):1-5. PubMed ID: 12255961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal bleeding patterns in users of Perlutal, a once-a-month injectable contraceptive consisting of 10 mg estradiol enanthate combined with 150 mg dihydroxyprogesterone acetophenide. A trial of 5462 woman-months.
    Martínez GH; Castañeda A; Correa JE
    Contraception; 1998 Jul; 58(1):21-7. PubMed ID: 9743892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of intramuscular injection as contraceptive compound.
    Lay CL
    Med Gynaecol Sociol; 1970; 5():7-9. PubMed ID: 12305458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial histology and parentereal estrogen-progestogen administration.
    Czernobilsky B; Garcia CR; Wallach EE
    Fertil Steril; 1969; 20(1):75-90. PubMed ID: 5762553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with injectable contraceptives.
    Statzer DE
    Appl Ther; 1969 Mar; 11(3):147-50. PubMed ID: 5778630
    [No Abstract]   [Full Text] [Related]  

  • 15. [Response of peripheral receptors to the parenteral administration of an association of dihydroxyprogesterone acetophenide and estradiol-3 benzoate-17-n-butyrate. Preliminary note].
    Selvaggi L; Putignano G
    Minerva Ginecol; 1975 Dec; 27(12):961-3. PubMed ID: 778679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroxyprogesterone acetophenide 150 mg + estradiol enantate 10 mg as monthly injectable contraceptives.
    Jarquín González JD; Elda de Aguirre L; Rodríguez C; Abrego de Aguilar M; Carrillo F; León DA; Lima M; Trigueros S; Acosta R
    Adv Contracept; 1996 Sep; 12(3):213-25. PubMed ID: 8910663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Side effects of depot contraceptives].
    Ruíz Velasco V; Alisedo Aparicio LE
    Prensa Med Mex; 1972; 37(1):25-9. PubMed ID: 5032612
    [No Abstract]   [Full Text] [Related]  

  • 18. DELADROXATE FOR THE PREVENTION OF OVULATION.
    RUTHERFORD RN; BANKS AL; COBURN WA
    Fertil Steril; 1964; 15():648-52. PubMed ID: 14236841
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of two regimens of a monthly injectable contraceptive containing dihydroxyprogesterone acetophenide and estradiol enanthate.
    Coutinho EM; Spinola P; Athayde C; Noronha CF; de Melo NR; Cabral ZA; Almeida JA; da Silva BL; Neto JS; Rumi DO
    Contraception; 2006 Mar; 73(3):249-52. PubMed ID: 16472564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of deladroxate as a monthly contraceptive injection.
    Karim M; El-mahgoub S; El-ganzoury B; Ammar R; Yaseen S; Fikri F
    Ain Shams Med J; 1971 May; 22(3):343-7. PubMed ID: 12264799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.